Save your place

Sign in to WhoBought

Please try again later.

Monte Rosa Therapeutics, Inc. (GLUE) institutional ownership

Latest close $22.78 Jul 24, 2026
Market cap$642M 52-week range SectorHealthcare
Funds holding · Q1 2026
188
reported GLUE position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
127 buyers · 61 sellers

Monte Rosa Therapeutics, Inc. (GLUE) price and institutional activity

Dates

Q1 2026

$0 bought by 127 investors
Vestal Point Capital, LPBraidwell LP +125 more
$0 sold by 61 investors
Versant Venture Management, LLCFMR LLC +59 more
Bought Sold Totals per quarter; hover a bar for the names.

Monte Rosa Therapeutics, Inc. (GLUE) institutional activity · 188

Investor Type Est. change Change Δ Own Date
Vestal Point Capital, LP · Added
Change +2.8M Date Q1 2026
Vestal Point Capital, LP Added· Q1 2026 +2.8M Q1 2026
Braidwell LP · Added
Change +2.3M Date Q1 2026
Braidwell LP Added· Q1 2026 +2.3M Q1 2026
T. Rowe Price Associates · Added
Change +1.6M Date Q1 2026
T. Rowe Price Associates Added· Q1 2026 +1.6M Q1 2026
American Century Companies Inc · Added
Change +1.5M Date Q1 2026
American Century Companies Inc Added· Q1 2026 +1.5M Q1 2026
BlackRock · Added
Change +1.5M Date Q1 2026
BlackRock Added· Q1 2026 +1.5M Q1 2026
Bellevue Group AG · New
Change +1.2M Date Q1 2026
Bellevue Group AG New· Q1 2026 +1.2M Q1 2026
State Street · Added
Change +1.2M Date Q1 2026
State Street Added· Q1 2026 +1.2M Q1 2026
Versant Venture Management, LLC · Reduced
Change −1.2M Date Q1 2026
Versant Venture Management, LLC Reduced· Q1 2026 −1.2M Q1 2026
Marshall Wace, LLP · Added
Change +1.0M Date Q1 2026
Marshall Wace, LLP Added· Q1 2026 +1.0M Q1 2026
Frazier Life Sciences Management, L.P. · New
Change +1.0M Date Q1 2026
Frazier Life Sciences Management, L.P. New· Q1 2026 +1.0M Q1 2026
Silverarc Capital Management, LLC · Added
Change +973K Date Q1 2026
Silverarc Capital Management, LLC Added· Q1 2026 +973K Q1 2026
Suvretta Capital Management, LLC · Added
Change +867K Date Q1 2026
Suvretta Capital Management, LLC Added· Q1 2026 +867K Q1 2026
Vanguard · Added
Change +842K Date Q1 2026
Vanguard Added· Q1 2026 +842K Q1 2026
Goldman Sachs Group Inc · Added
Change +706K Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +706K Q1 2026
Janus Henderson Group PLC · New
Change +686K Date Q1 2026
Janus Henderson Group PLC New· Q1 2026 +686K Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
15 of 188

Famous investor activity in Monte Rosa Therapeutics, Inc. (GLUE)

Monte Rosa Therapeutics, Inc. (GLUE) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Warmuth Markus · Director Sell −$220K
Price $23.18 Qty −10K Owned 585K ΔOwn −1.6% Trade date Jul 16, 2026 Filed date Jul 17, 2026
Warmuth Markus Director Sell $23.18 −10K −$220K 585K −1.6% Jul 16, 2026 Jul 17, 2026
Champoux Jennifer · Officer Sell −$102K
Price $23.38 Qty −4K Owned 62K ΔOwn −6.5% Trade date Jul 15, 2026 Filed date Jul 16, 2026
Champoux Jennifer Officer Sell $23.38 −4K −$102K 62K −6.5% Jul 15, 2026 Jul 16, 2026
Champoux Jennifer · Officer 2 operations 0
Price $3.98 Owned 27K Trade date Jul 15, 2026 Filed date Jul 16, 2026
Champoux Jennifer Officer 2 operations $3.98 0 27K Jul 15, 2026 Jul 16, 2026
Townson Sharon · Officer 2 operations −$140K
Price $23.25–$24.13 Qty −6K Owned 68K ΔOwn −8.1% Trade date Jul 6, 2026 Filed date Jul 7, 2026
Townson Sharon Officer 2 operations $23.25–$24.13 −6K −$140K 68K −8.1% Jul 6, 2026 Jul 7, 2026
Townson Sharon · Officer 2 operations 0
Price $6.14 Owned 197K Trade date Jul 6, 2026 Filed date Jul 7, 2026
Townson Sharon Officer 2 operations $6.14 0 197K Jul 6, 2026 Jul 7, 2026
Behbahani Ali · Director 3 operations -1.0M
Owned 0 Trade date Jul 1, 2026 Filed date Jul 6, 2026
Behbahani Ali Director 3 operations -1.0M 0 Jul 1, 2026 Jul 6, 2026
Janku Filip · Officer Sell −$132K
Price $24.50 Qty −5K Owned 61K ΔOwn −8.2% Trade date Jun 30, 2026 Filed date Jul 1, 2026
Janku Filip Officer Sell $24.50 −5K −$132K 61K −8.2% Jun 30, 2026 Jul 1, 2026
Janku Filip · Officer 2 operations 0
Price $13.41 Owned 81K Trade date Jun 30, 2026 Filed date Jul 1, 2026
Janku Filip Officer 2 operations $13.41 0 81K Jun 30, 2026 Jul 1, 2026
Janku Filip · Officer Sell −$138K
Price $22.95 Qty −6K Owned 60K ΔOwn −9.1% Trade date Jun 29, 2026 Filed date Jun 30, 2026
Janku Filip Officer Sell $22.95 −6K −$138K 60K −9.1% Jun 29, 2026 Jun 30, 2026
Janku Filip · Officer 2 operations 0
Price $7.56 Owned 60K Trade date Jun 29, 2026 Filed date Jun 30, 2026
Janku Filip Officer 2 operations $7.56 0 60K Jun 29, 2026 Jun 30, 2026
Manning Anthony M. · Director Sell −$231K
Price $23.11 Qty −10K Owned 0 ΔOwn −100.0% Trade date Jun 29, 2026 Filed date Jun 30, 2026
Manning Anthony M. Director Sell $23.11 −10K −$231K 0 −100.0% Jun 29, 2026 Jun 30, 2026
Manning Anthony M. · Director 2 operations 0
Price $4.16 Owned 2K Trade date Jun 29, 2026 Filed date Jun 30, 2026
Manning Anthony M. Director 2 operations $4.16 0 2K Jun 29, 2026 Jun 30, 2026
Janku Filip · Officer Sell −$643K
Price $21.42 Qty −30K Owned 60K ΔOwn −33.3% Trade date Jun 24, 2026 Filed date Jun 25, 2026
Janku Filip Officer Sell $21.42 −30K −$643K 60K −33.3% Jun 24, 2026 Jun 25, 2026
Janku Filip · Officer 2 operations 0
Price $7.56 Owned 66K Trade date Jun 24, 2026 Filed date Jun 25, 2026
Janku Filip Officer 2 operations $7.56 0 66K Jun 24, 2026 Jun 25, 2026
Janku Filip · Officer Sell −$240K
Price $20.22 Qty −12K Owned 60K ΔOwn −16.5% Trade date Jun 23, 2026 Filed date Jun 25, 2026
Janku Filip Officer Sell $20.22 −12K −$240K 60K −16.5% Jun 23, 2026 Jun 25, 2026
15 of 63
15 of 63 Sign in to continue to older insider transactions.

Monte Rosa Therapeutics, Inc. (GLUE) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
T. Rowe Price Associates, Inc. 8.9M
% of shares outstanding 10.5% Filing date Jul 8, 2026
T. Rowe Price Associates, Inc. 8.9M 10.5% Jul 8, 2026
Baker Bros. Advisors LP 8.9M
% of shares outstanding 10.0% Filing date May 15, 2026
Baker Bros. Advisors LP 8.9M 10.0% May 15, 2026
Avoro Capital Advisors LLC 4.3M
% of shares outstanding 8.9% Filing date Feb 14, 2023
Avoro Capital Advisors LLC 4.3M 8.9% Feb 14, 2023
FMR LLC 5.1M
% of shares outstanding 8.3% Filing date Nov 12, 2024
FMR LLC 5.1M 8.3% Nov 12, 2024
Adam Goulburn 6.5M
% of shares outstanding 8.1% Filing date Apr 22, 2026
Adam Goulburn 6.5M 8.1% Apr 22, 2026
Versant Venture Capital Vi, L.P. 4.1M
% of shares outstanding 6.6% Filing date Oct 30, 2024
Versant Venture Capital Vi, L.P. 4.1M 6.6% Oct 30, 2024
BlackRock Inc. 2.4M
% of shares outstanding 4.7% Filing date Feb 14, 2024
BlackRock Inc. 2.4M 4.7% Feb 14, 2024
Biotechnology Value Fund L P 2.7M
% of shares outstanding 3.4% Filing date May 15, 2026
Biotechnology Value Fund L P 2.7M 3.4% May 15, 2026
8 of 10

Monte Rosa Therapeutics, Inc. (GLUE) ownership FAQ

Who owns GLUE?

188 reporting institutions disclosed GLUE position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.